BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 38662379)

  • 1. Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21
    Neuwahl J; Neumann CA; Fitz AC; Biermann AD; Magel M; Friedrich A; Sellin L; Stork B; Piekorz RP; Proksch P; Budach W; Jänicke RU; Sohn D
    Cell Death Dis; 2024 May; 15(5):373. PubMed ID: 38811535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer.
    Inkoom A; Ndemazie NB; Smith T; Frimpong E; Bulusu R; Poku R; Zhu X; Han B; Trevino J; Agyare E
    BMC Cancer; 2023 May; 23(1):435. PubMed ID: 37179357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Strategies for the Detection and Elimination of Senescent Cells.
    García-Fleitas J; García-Fernández A; Martí-Centelles V; Sancenón F; Bernardos A; Martínez-Máñez R
    Acc Chem Res; 2024 May; 57(9):1238-1253. PubMed ID: 38604701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senolysis of gemcitabine-induced senescent human pancreatic cancer cells.
    Hoque MM; Iida Y; Kotani H; Harada M
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2075. PubMed ID: 38662379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
    Hari Y; Harashima N; Tajima Y; Harada M
    Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in Pancreatic Cancer in vitro and in vivo.
    Zhou Y; Liu H; Xue R; Tang W; Zhang S
    Dig Dis Sci; 2018 Dec; 63(12):3367-3375. PubMed ID: 30155839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MGMT expression affects the gemcitabine resistance of pancreatic cancer cells.
    Shi Y; Wang Y; Qian J; Yan X; Han Y; Yao N; Ma J
    Life Sci; 2020 Oct; 259():118148. PubMed ID: 32721465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63.
    Ozaki T; Nakamura M; Ogata T; Sang M; Yoda H; Hiraoka K; Sang M; Shimozato O
    Oncotarget; 2016 Nov; 7(44):71937-71950. PubMed ID: 27713122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proapoptotic and antiapoptotic proteins of the Bcl-2 family regulate sensitivity of pancreatic cancer cells toward gemcitabine and T-cell-mediated cytotoxicity.
    Bauer C; Hees C; Sterzik A; Bauernfeind F; Mak'Anyengo R; Duewell P; Lehr HA; Noessner E; Wank R; Trauzold A; Endres S; Dauer M; Schnurr M
    J Immunother; 2015 Apr; 38(3):116-26. PubMed ID: 25751501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting chemoresistant senescent pancreatic cancer cells improves conventional treatment efficacy.
    Jaber S; Warnier M; Leers C; Vernier M; Goehrig D; Médard JJ; Vindrieux D; Ziegler DV; Bernard D
    Mol Biomed; 2023 Feb; 4(1):4. PubMed ID: 36739330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective roles of cytoplasmic p21
    Koyanagi A; Kotani H; Iida Y; Tanino R; Kartika ID; Kishimoto K; Harada M
    Cell Prolif; 2022 Dec; 55(12):e13326. PubMed ID: 36054146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular senescence and senolytics: the path to the clinic.
    Chaib S; Tchkonia T; Kirkland JL
    Nat Med; 2022 Aug; 28(8):1556-1568. PubMed ID: 35953721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of cytoplasmic p21Cip1/Waf1 in apoptosis of CDK4/6 inhibitor-induced senescence in breast cancer cells.
    Kartika ID; Kotani H; Iida Y; Koyanagi A; Tanino R; Harada M
    Cancer Med; 2021 Dec; 10(24):8988-8999. PubMed ID: 34761877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors.
    Klein AP
    Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):493-502. PubMed ID: 34002083
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.